Literature DB >> 22328902

Pregnant heroin addict: what about the baby?

Vasudevan Namboodiri1, Sanju George, Sylvie Boulay, Mandy Fair.   

Abstract

Heroin misuse in pregnancy is a significant health and social problem, and it can have an adverse effect on the mother and the baby. Although heroin and methadone have no specific teratogenic potential, 48-94% of children exposed in utero will have neonatal abstinence syndrome (NAS). The primary aim of this case report is to raise awareness of NAS among clinicians and to remind them that although very common, it is not inevitable. The risk of NAS can be further minimised by offering comprehensive and co-ordinated antenatal care that addresses the various biopsychosocial needs of the pregnant woman. Further, a brief description of NAS and a review of evidence in the field of management of opioid misuse in pregnancy, as relevant to this case, are provided. We have also included the patient's own reflections on her pregnancy and treatment.

Entities:  

Year:  2010        PMID: 22328902      PMCID: PMC3029977          DOI: 10.1136/bcr.09.2009.2246

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  6 in total

1.  Comparing opiate users in methadone treatment with untreated opiate users: results of a follow-up study with a Toronto opiate user cohort.

Authors:  B Fischer; L Gliksman; J Rehm; N Daniel; W Medved
Journal:  Can J Public Health       Date:  1999 Sep-Oct

2.  Substance misuse during pregnancy.

Authors:  K Johnson; C Gerada; A Greenough
Journal:  Br J Psychiatry       Date:  2003-09       Impact factor: 9.319

3.  Neonatal abstinence syndrome.

Authors:  D Coghlan; M Milner; T Clarke; I Lambert; C McDermott; M McNally; M Beckett; T Matthews
Journal:  Ir Med J       Date:  1999 Jan-Feb

4.  Outpatient methadone programme for pregnant heroin using women.

Authors:  W Giles; T Patterson; F Sanders; R Batey; D Thomas; J Collins
Journal:  Aust N Z J Obstet Gynaecol       Date:  1989-08       Impact factor: 2.100

5.  The Opioid dependent mother and newborn dyad: non-pharmacologic care.

Authors:  Martha Velez; Lauren M Jansson
Journal:  J Addict Med       Date:  2008-09       Impact factor: 3.702

6.  The effects of maternally administered methadone, buprenorphine and naltrexone on offspring: review of human and animal data.

Authors:  W O Farid; S A Dunlop; R J Tait; G K Hulse
Journal:  Curr Neuropharmacol       Date:  2008-06       Impact factor: 7.363

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.